Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q1 2017 · 10-Q
Revenue$500.10M$500.10M+6.1% vs Q1 2016 Net Income$12.40M$12.40M+12.7% vs Q1 2016 EPS Diluted$0.41$0.41+10.8% vs Q1 2016 Gross Profit$270,100,000+2.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flow-$56,203,000N/M Free Cash Flowderived-$95,535,000N/M Margins · derivedGross margin54.0%−2.0 pt vs Q1 2016
Operating margin5.2%+1.0 pt vs Q1 2016
Net margin2.5%+0.1 pt vs Q1 2016
ended Mar 31, 2017 · filed May 9, 2017 · 39 d after period end